Project information
Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies
- Project Identification
- MSM0021622430
- Project Period
- 1/2007 - 12/2013
- Investor / Pogramme / Project type
-
Ministry of Education, Youth and Sports of the CR
- Research Intents
- MU Faculty or unit
- Faculty of Medicine
- Other MU Faculty/Unit
- Faculty of Science
- Other MU Faculty/Unit
- Faculty of Informatics
- Other MU Faculty/Unit
- Central European Institute of Technology
- Keywords
- embryonic stem cells
The goal of this project will be a) to profit from availability of unique cellular resources - mouse and human embryonic stem cells and normal and malignant hematopoietic stem/progenitor cells, b) to effectively employ a wide variety of current and complementary methodologies available to the consortium, and c) to exploit a proven/certified expertise in working with various living systems that span from in vitro cultured cells, through animal models to oncohematological patients. All this together will represent a powerful experimental platform aimed at addressing a nature of molecules and molecular mechanisms underlaying phenomena that are common to both normal and cancer stem cells, mainly their ability to self-renew and to enter differentiation pathways. Integral part of this general goal is to implement multifaceted analytical approach that will cover studies of gene expression at both mRNA and protein levels, evaluating function of extra and intracellular signaling pathways, and analyzing biological properties of cells in vitro and in vivo. Expected outcome will be not only understanding but also a definition of molecules and/or molecular pathways to be tested as therapeutic targets, and cellular models that will make such testing feasible.
Publications
Total number of publications: 357
2010
-
Nf449 is a novel inhibitor of fibroblast growth factor receptor 3 (fgfr3) signaling active in chondrocytes and multiple myeloma cells
J. Biol. Chem., year: 2010, volume: 285, edition: 27, DOI
-
NON SCID GAMMA Mouse as a Model for Chronic Lymphocytic Leukemia
Year: 2010, type: Conference abstract
-
Non-hodgkin lymphoma subtypes classification using focused microarray
Year: 2010, type: Conference abstract
-
Nové prognostické markery u chronické lymfocytární leukemie v každodenní hematologické praxi. Analýza dat ze čtyř pracovišť.
Transfuze a hematologie dnes, year: 2010, volume: 16, edition: Suppl.1
-
PCR detection of non-mtc T(11;14) translocations in mantle cell lymphoma
Year: 2010, type: Conference abstract
-
Persistent splenomegaly during imatinib therapy and the definition of complete hematological response in chronic myelogenous leukemia.
American Journal of Hematology, year: 2010, volume: 85, edition: 5
-
Průkaz těžkých kovů v ledvinách fétů po perorálním podávání olova, rtuti a kadmia březím myším samicím
Plzeňský lékařský sborník, year: 2010
-
Rearrangement of lambda immunoglobulin light chain in CLL is coupled with expression of miRNA-650
Year: 2010, type:
-
Sledování mutací v exonu 4 genů IDH1 a IDH2 u pacientů s akutní myeloidní leukémií
Year: 2010, type: Conference abstract
-
Stanovení intracelulární koncentrace imatinibu u CML pacientů
Year: 2010, type: Conference abstract